AbbVie ( ABBV -0.27%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...
The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...
Investor's Business Daily on MSN7h
Is Moderna Stock A Sell With Robert F. Kennedy Eyeing The Lead Role At HHS?Moderna stock tumbled after the Senate Finance Committee voted to send RFK Jr.'s nomination for the HHS secretary to the full ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...
Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...
Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...
Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...
SiriusXM’s Megyn Kelly said Friday during her show that she would be watching Republican Louisiana Sen. Bill Cassidy’s vote ...
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback